NCT04970472Recruiting
Bio Clinical Collection of Urothelial Carcinoma
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
The goal of this study is to collect tumor samples, urines, stool and blood from patients with urothelial carcinoma. These samples will be stored in a secure and confidential laboratory of the Toulouse University Hospital.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 8 Jul 2021
- Start date
- 16 Nov 2021
- Primary completion date
- 14 Jul 2026
- Lead sponsor
- University Hospital, Toulouse
- Diseases
- Bladder cancer
- NCT number
- NCT04970472
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 16 Nov 2021 to the primary completion date, 14 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients under 18 years old
Other
- Pregnant or breastfeeding patients
- Patients under guardianship or curators
- Patients unable to sign a free and informed consent
Who the study is looking for
- Adult \>18 years old
- Patient with suspected or diagnosed Urothelial carcinoma
- Patients who are willing to consent for this protocol.
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rangueil University Hospital Coordinator of this site? Confirm its status | Toulouse | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.